Back to Companies
Mersana Therapeutics, Inc.
MRSNCIK: 0001442836
Mersana Therapeutics, Inc. (MRSN) shows 12 recent insider filings from 10 insiders, with all of them on the sell side. With $0 in purchases and $15.5K in sales, the recent tape is heavily weighted toward selling (net sales of $15.5K). Lowinger Timothy B (SVP, Chief Sci.&Tech. Officer) is the most active by dollar volume, and the single largest transaction was $6.9M by Lowinger Timothy B. All figures are drawn from official SEC Form 3, 4, and 5 disclosures and update as new filings arrive.
Total Volume
$28.4M
Purchases
$0
Sales
$15.5K
Unique Insiders
10
Recent Insider Trades
12 loaded
| Jan 6 | MRSN Mersana Therapeutics, Inc. | Bala Mohan | SVP, Chief Development | Disposed | $2.9M |
| Jan 6 | MRSN Mersana Therapeutics, Inc. | Hack Andrew A. F. | Insider | Disposed | $1.7M |
| Jan 6 | MRSN Mersana Therapeutics, Inc. | Mandelia Ashish | VP, Chief Accounting Officer | Disposed | $1.7M |
| Jan 6 | MRSN Mersana Therapeutics, Inc. | Hege Kristen | Director | Disposed | $1.8M |
| Jan 6 | MRSN Mersana Therapeutics, Inc. | Alleva Lawrence M | Director | Disposed | $2.1M |
| Jan 6 | MRSN Mersana Therapeutics, Inc. | Dere Willard H | Director | Disposed | $1.8M |
| Jan 6 | MRSN Mersana Therapeutics, Inc. | Carvajal Alejandra | SVP, Chief Legal Officer | Disposed | $4.0M |
| Jan 6 | MRSN Mersana Therapeutics, Inc. | Huber Martin H. Jr. | President, CEO, Director | Disposed | $3.7M |
| Jan 6 | MRSN Mersana Therapeutics, Inc. | Lowinger Timothy B | SVP, Chief Sci.&Tech. Officer | Disposed | $6.9M |
| Jan 6 | MRSN Mersana Therapeutics, Inc. | MOTT DAVID M | Director | Disposed | $1.8M |
| Oct 28 | MRSN Mersana Therapeutics, Inc. | Bala Mohan | SVP, Chief Development Officer | Sell | $762 |
| Sep 15 | MRSN Mersana Therapeutics, Inc. | Huber Martin H. Jr. | President, CEO, Director | Sell | $14.7K |
12 filings